CHICAGO — Valacyclovir can be beneficial for treating multiple episodes of keratitis or iritis in patients with herpes zoster ophthalmicus, according to a speaker here.
Elisabeth Cohen, MD, presented results from the Zoster Eye Disease Study (ZEDS) during Cornea Subspecialty Day at the American Academy of Ophthalmology meeting. ZEDS was a double-masked, multicenter randomized controlled trial with the primary objective of determining if valacyclovir 1,000 mg daily is beneficial at 12 months for delaying time to occurrence of herpes zoster ophthalmicus manifestations including dendriform